Correlation of allelic loss with poor postoperative survival in breast cancer

Breast Cancer

Volumn 6, Issue 4, 1999, Pages 351-356

  Emi, Mitsuru ^a,b   Utada, Yoshihito ^a,c   Yoshimoto, Masataka ^b   Sato, Takaaki ^b   Minobe, Kaori ^a   Matsumoto, Satoshi ^a   Akiyama, Futoshi ^b   Iwase, Takuji ^b   Haga, Shunsuke ^c   Kajiwara, Tetsuro ^c   Sakamoto, Goi ^b   Kasumi, Fujio ^b   Nakamura, Yusuke ^b,d  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Allelic loss; Breast cancer; Postoperative survival; Prognostic marker; Tumor suppressor gene

Indexed keywords

EID: 84863229202     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966452     Document Type: Review

References (28)

1. Callahan R, Campbell G: Mutations in human breast cancer; An overview. J Natl Cancer Inst 81:1780-1786, 1989. (Pubitemid 20001421)
2. Knudson AG: Anti-oncogenes and human cancer. Proc Natl Acad Sci USA 90:10914-10921, 1993.
3. Harris JR, Henderson IC: Staging and prognostic factors. In: Harris JR ed, Breast Diseases, pp327-346, Philadelphia, 1987.
4. McGuire W, Clark G: Prognostic factors and treatment decision in axillary node-negative breast cancers. N Engl J Med 326:1756-1761, 1992.
5. Sato T, Tanigami A, Yamakawa K, et al: Allelotype of breast cancer; Cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50:7184-7189, 1990.
6. Sato T, Akiyama F, Sakamoto G, et al: Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51:5794-5799, 1991.
7. Takita K, Sato T, Miyagi M, et al: Correlation of loss of alleles on the short Arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 52:3914-3917, 1992.
8. Saito H, Inazawa J, Saito S, et al: Detailed deletion mapping of chromosome 17q in ovarian and breast cancers; 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 53:3382-3385, 1993. (Pubitemid 23223313)
9. Harada Y, Katagiri T, Ito I, et al: Genetic studies of 457 breast cancers; Clinicopathologic parameters compared with genetic alterations. Cancer 74:2281-2286, 1994. (Pubitemid 24322283)
10. Ito I, Yoshimoto M, Iwase T, et al: Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer 71:438-441, 1995.
11. Tsukamoto K, Ito N, Yoshimoto M, et al: Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas. Cancer 78:1929-1934, 1996. (Pubitemid 26360576)
12. Tsukamoto K, Ito N, Yoshimoto M, et al: Allelic loss on chromosome lp is associated with progression and lymph node metastasis of primary breast carcinoma. Cancer 82:317-322, 1998. (Pubitemid 28060248)
13. Iida A, Isobe R, Yoshimoto M, et al: Localization of a breast cancer tumor-suppressor gene to a 3-cM interval within chromosomal region 16p22. Br J Cancer 75:264-267, 1997. (Pubitemid 27019572)
14. Iida A, Kurose K, Isobe R, et al: Mapping of a new target region of allelic loss to a 2-cM interval at 22ql3.1 in primary breast cancer. Genes Chrom Cancer 21:108-112, 1998. (Pubitemid 28081236)
15. Matsumoto S, Kasumi F, Sakamoto G, et al: Detailed deletion mapping of chromosome arm 3p in breast cancer; A 2-cM region on 3pl4.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors. Genes Chrom Cancer 20:1-7, 1997.
16. Yokota T, Matsumoto S, Yoshimoto M, et al: Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21. Jpn J Cancer Res 88:959-964, 1997. (Pubitemid 27507392)
17. Nakata T, Yoshimoto M, Kasumi F, et al: Identification of a new commonly deleted region within a 2-cM interval of 11p11 in breast cancers. Eur J Cancer 34:417-421, 1998. (Pubitemid 28183845)
18. Japanese Breast Cancer Society: The general rules for clinical and pathological recording of breast cancer. Jpn J Surg 19:612-632, 1989.
19. Dib C, Faure S, Fizames C: A comprehensive gene-tic map of the human genome based on 5,264 microsatellites. Nature 380:152-154, 1996. (Pubitemid 26085878)
20. Slamon DJ, Clark GM, Wong SG, et al: Human breast cancer; Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182, 1987. (Pubitemid 17231334)
21. Varley JM, Swallow JE, Brammar WJ, et al: Alterations to either c-erbB2 or c-myc proto-oncogenes in breast carcinoma correlate with poor short-term prognosis. Oncogene 1:423-430, 1987. (Pubitemid 17159256)
22. Borg A, Tandon AK, Sigurdsson H, et al: HER-2/new amplification predicts poor survival in node-positive breast cancer. Cancer Res 50:4332-4337, 1990. (Pubitemid 20225674)
23. Berns EM, Klijn JGM, Van Staveren IL, et al: Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours; Correlation with steroid receptors. Eur J Cancer 213:697-700, 1992.
24. Tompson AM, Steel CM, Chetty U, et al: p53 gene mRNA expression and chromosome 17p allele loss in breast cancer. Br J Cancer 61:74-78, 1990. (Pubitemid 20043549)
25. Deng G, Chen LC, Schott DR, et al: Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 54:499-505, 1994. (Pubitemid 24053192)
26. Bieche I, Champene MH, Matifas F, et al: Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer. Lancet 339:139-143, 1992.
27. Catzavelos C, Bhattacharya N, Ung Y, et al: Decreased levels of the cell-cycle inhibitor p27-Kipl protein; Prognostic implications in primary breast cancer. Nat Med 3:227-230, 1997. (Pubitemid 27064710)
28. Porter P, Malone KE, Heagerty PJ, et al: Expression of cell-cycle regulators p27-kipl and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3:222-225, 1997. (Pubitemid 27064709)